Anavex Life Sciences Corp.
Status: Publicly traded
Direct answer
Anavex Life Sciences Corp. is publicly traded on NASDAQ under the ticker AVXL.
Operating as a clinical-stage biopharmaceutical entity, Anavex Life Sciences Corp. specializes in developing therapeutic drug candidates for various central nervous system (CNS) conditions. Its leading compound, ANAVEX 2-73, is currently in advanced development, undergoing Phase III clinical evaluation for both Alzheimer's disease and pediatric Rett syndrome. This same drug is also in Phase II trials for Parkinson's...
Can you invest in Anavex Life Sciences Corp.?
Yes. Anavex Life Sciences Corp. is publicly traded on NASDAQ under the ticker AVXL.
View deeper analysis
View detailed research on MarketSnap, including financials, valuation tools, and analyst context.
Open research for Anavex Life Sciences Corp.
Detailed equity research is provided by MarketSnap.